Profusa, Inc. Common Stock - Asset Resilience Ratio
Profusa, Inc. Common Stock (PFSA) has an Asset Resilience Ratio of 22.87% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (None–None)
This chart shows how Profusa, Inc. Common Stock's Asset Resilience Ratio has changed over time. See Profusa, Inc. Common Stock (PFSA) financial flexibility to measure the company's free cash flow as a share of total liabilities.
Liquid Assets Composition Over Time
This chart breaks down Profusa, Inc. Common Stock's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see PFSA company net worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $972.00K | 22.87% |
| Total Liquid Assets | $972.00K | 22.87% |
Asset Resilience Insights
- Good Liquidity Position: Profusa, Inc. Common Stock maintains a healthy 22.87% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Profusa, Inc. Common Stock Industry Peers by Asset Resilience Ratio
Compare Profusa, Inc. Common Stock's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
Shanghai Sanyou Medical Co Ltd
SHG:688085 |
Medical Devices | 7.69% |
|
Heramed Ltd
AU:HMD |
Medical Devices | 0.83% |
|
Nova EYE Medical Ltd
AU:EYE |
Medical Devices | 11.08% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
Annual Asset Resilience Ratio for Profusa, Inc. Common Stock (None–None)
The table below shows the annual Asset Resilience Ratio data for Profusa, Inc. Common Stock.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| No yearly data available. | ||||
About Profusa, Inc. Common Stock
Profusa, Inc., a digital health technology company, develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platf… Read more